The company owns Al-Ahli Hospital in Doha with comprehensive clinical departments and ancillary services spanning emergency care, surgery, cardiology, gynecology, and intensive care units. The company demonstrates strong financial discipline with consistent dividend payouts, positioning itself as a stable healthcare operator in a growing Middle Eastern market.
Cyborg Score Rationale
The company's revenue increased 7.72% to 523.49 million in 2024, demonstrating steady market growth. The dividend yield is 3.21%, reflecting shareholder-friendly capital allocation. However, earnings declined 8.59% in 2024, suggesting margin pressure despite revenue growth.
Top Insights
Consistent 3%+ dividend yield with annual payouts, attractive for income-focused investors
Revenue growth of 7.72% (2024) indicates healthy demand for healthcare services in Qatar